Parallel Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-122
Closed -$3K 3618
2022
Q3
$3K Sell
122
-16
-12% -$333 ﹤0.01% 2561
2022
Q2
$3K Buy
138
+70
+103% +$1.25K ﹤0.01% 2515
2022
Q1
$1K Hold
68
﹤0.01% 2911
2021
Q4
$1K Hold
68
﹤0.01% 3022
2021
Q3
$1K Hold
68
﹤0.01% 3017
2021
Q2
$2K Hold
68
﹤0.01% 2652
2021
Q1
$2K Hold
68
﹤0.01% 2552
2020
Q4
$2K Hold
68
﹤0.01% 2377
2020
Q3
$2K Hold
68
﹤0.01% 2378
2020
Q2
$1K Sell
68
-422
-86% -$5.55K ﹤0.01% 2405
2020
Q1
$3K Buy
490
+422
+621% +$4.82K ﹤0.01% 2079
2019
Q4
$1K Sell
68
-6
-8% -$73 ﹤0.01% 2375
2019
Q3
$1K Hold
74
﹤0.01% 2357
2019
Q2
$2K Buy
+74
New +$2.13K ﹤0.01% 2146

Other funds holding CVET

Parallel Advisors's CVET Position: Q4 2022 in Review

Parallel Advisors sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 122 shares — an estimated $3K sold.

Parallel Advisors first reported a position in CVET in Q2 2019 and held it in 14 quarters. The position peaked at $3K in Q3 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Parallel Advisors reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Parallel Advisors sold 122 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Parallel Advisors first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Parallel Advisors's Covetrus, Inc. Common Stock position peaked at $3K in Q3 2022.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Parallel Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.